Track topics on Twitter Track topics that are important to you
Established in 1982, Immucor, Inc. was founded by a team of executives with over 200 years of combined blood bank industry experience. The Company's patented Capture® technology received its first license in 1986. This solid phase technology performs antibody screening and identification assays, providing an easy-to-use, standardized test method with improved sensitivity. In addition to manual testing benefits, this microplate-based technology is ideally suited for automated platforms. Immucor began revolutionizing the blood bank industry through the inven-tion of the ABS2000, the first FDA-cleared (1998) instrument for full auto-mation of blood typing and antibody screening assays. Immucor's second generation system, the Galileo, was launched in Europe in 2002 and received FDA clearance to market in the US on April 26, 2004. Since its inception, the Company has grown to almost 500 employees world-wide and has acquired both Gamma Biologicals, Inc. (1998) and the BCA blood bank division of Biopool International, Inc. (1999). As a result of these acquisitions, Immucor became the North American market leader in terms of sales and strengthened its market position worldwide. FY 2003 revenues totaled a record $98.3 million. In 2003, the Atlanta Journal and Constitution newspaper recognized Immucor as the second best performing company in Georgia. Immucor has been listed on NASDAQ : BLUD since 1985.
3130 Gateway Drive
United States of America
Phone: 770 441 2051
Fax: 770 441 3807
Immucor: Market Shares and Competitive Position by Product and CountryPerformance, Capabilities, Goals and Strategies in the Global Diagnostics Industry [Report Updated: 24082017] Prices from USD $2450
This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates b...
Life Sciences Jobs ...
Life Sciences Jobs ...
SummaryImmucor, Inc. Immucor is an invitro diagnostics company, which specializes in the area of pretransfusion diagnostics. It carries out the development, production and sale of a comprehensive line...
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cel...
Established in 1982, Immucor, Inc. was founded by a team of executives with over 200 years of combined blood bank industry experience. The Company's patented Capture® technology received its first li...
Somagen was founded as Immucor Canada Inc. in 1988 by Thomas E Brown and Roland Person. In its early days the business focused on supplying the Canadian Blood Bank market. By 1995 the company had begu...
We have published hundreds of Immucor news stories on BioPortfolio along with dozens of Immucor Clinical Trials and PubMed Articles about Immucor for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immucor Companies in our database. You can also find out about relevant Immucor Drugs and Medications on this site too.
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...